Les Sulewski
Stock Analyst at Truist Securities
(1.08)
# 3,852
Out of 5,116 analysts
14
Total ratings
53.85%
Success rate
-12.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $26.51 | +5.62% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $49.84 | -3.69% | 3 | Nov 7, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $31.89 | -21.61% | 1 | May 28, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $12.95 | -7.34% | 3 | Oct 2, 2024 |
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $26.51
Upside: +5.62%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $49.84
Upside: -3.69%
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $31.89
Upside: -21.61%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $12.95
Upside: -7.34%